Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rochester, NY
NPI
1760422521
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2655 Ridgeway Ave, Suite 220
Rochester, NY, 14626
Phone (585) 368-4560
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
393 services
Medicare patients, 2024
225
Average age 68
Drug cost, 2024
$3.9M
9,181 prescriptions
Company payments, 2025
$9,305
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Krishnakumar Rajamani was code 99213 (office e&m - established), 172 times for 122 patients. In total Krishnakumar Rajamani billed 393 services in 9 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 172 | 122 | $46.66 | $8,025 |
| 99214 Office E&M - Established | Office | 143 | 92 | $72.66 | $10K |
| 99204 Office E&M - New | Office | 28 | 28 | $91.91 | $2,573 |
| 99231 Hospital E&M - Subsequent | Facility | 27 | 13 | $38.21 | $1,032 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $138.99 | $1,807 |
By year: 2022 $25K for 459 services; 2023 $26K for 443 services; 2024 $25K for 393 services.
Medicare prescription drug claims, 2024
In 2024, the drug Krishnakumar Rajamani prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 1,080 prescriptions and refills. In total Krishnakumar Rajamani wrote 9,181 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 1,080 | 2,314 | 317 | $184K |
| Levothyroxine Sodium Generic | 1,050 | 2,558 | 270 | $14K |
| Ozempic Semaglutide | 932 | 1,110 | 184 | $995K |
| Trulicity Dulaglutide | 432 | 509 | 78 | $485K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 404 | 694 | 138 | $134K |
| Metformin Hcl Generic | 347 | 844 | 100 | $3,636 |
| Jardiance Empagliflozin | 338 | 580 | 79 | $324K |
| Humalog Kwikpen U-100 Insulin Lispro | 314 | 604 | 100 | $130K |
| Methimazole Generic | 254 | 481 | 62 | $1,842 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 191 | 406 | 74 | $22K |
| Glipizide Generic | 175 | 435 | 57 | $2,242 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 169 | 344 | 67 | $86K |
| Metformin Hcl Er Metformin Hcl | 158 | 402 | 51 | $3,703 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 156 | 345 | 60 | $21K |
| Novolog Flexpen Insulin Aspart | 151 | 277 | 56 | $41K |
Brand drugs: 5,477 claims; generic drugs: 2,707 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Krishnakumar Rajamani $9,305 ($9,305 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $9,305.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 22 | $9,305 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.